Ethane;N-(1-pyridin-3-ylpropyl)-2-(1-pyridin-3-ylpropylamino)thieno[3,2-d]pyrimidine-4-carboxamide
C25H30N6OS — CID 142540083
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethane;N-(1-pyridin-3-ylpropyl)-2-(1-pyridin-3-ylpropylamino)thieno[3,2-d]pyrimidine-4-carboxamide
Ethane;N-(1-pyridin-3-ylpropyl)-2-(1-pyridin-3-ylpropylamino)thieno[3,2-d]pyrimidine-4-carboxamide (PubChem CID 142540083) has the molecular formula C25H30N6OS and a molecular weight of 462.62 g/mol. Its IUPAC name is ethane;N-(1-pyridin-3-ylpropyl)-2-(1-pyridin-3-ylpropylamino)thieno[3,2-d]pyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | Ethane;N-(1-pyridin-3-ylpropyl)-2-(1-pyridin-3-ylpropylamino)thieno[3,2-d]pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 142540083 |
| Molecular Formula | C25H30N6OS |
| Molecular Weight | 462.62 g/mol |
| Exact Mass | 462.22 |
| IUPAC Name | ethane;N-(1-pyridin-3-ylpropyl)-2-(1-pyridin-3-ylpropylamino)thieno[3,2-d]pyrimidine-4-carboxamide |
| SMILES | CC.CCC(NC(=O)c1nc(NC(CC)c2cccnc2)nc2ccsc12)c1cccnc1 |
| InChI | InChI=1S/C23H24N6OS.C2H6/c1-3-17(15-7-5-10-24-13-15)26-22(30)20-21-19(9-12-31-21)28-23(29-20)27-18(4-2)16-8-6-11-25-14-16;1-2/h5-14,17-18H,3-4H2,1-2H3,(H,26,30)(H,27,28,29);1-2H3 |
| InChIKey | YIKIFBHDMXRIMS-UHFFFAOYSA-N |
| XLogP | 5.95 |
| TPSA | 92.69 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.62 |
| LogP ≤ 5 | 5.95 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142540083 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.